Data for increased Rho kinase activity in type 2 diabetic patients

The data presented in this article are related to the research article entitled “Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes” [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Tan, Lun, Lai, Jinsheng, Li, Sheng, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120266/
https://www.ncbi.nlm.nih.gov/pubmed/27896306
http://dx.doi.org/10.1016/j.dib.2016.11.032
Descripción
Sumario:The data presented in this article are related to the research article entitled “Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes” [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the observed relationship of Rho-Kinase activity with type 2 diabetic patients. Rho-Kinase activity is determined by immunoblotting of peripheral blood leukocytes with the Phospho-Thr853 in the myosin-binding subunit of myosin light-chain phosphatase. The level of IL-6 is measured using Enzyme-linked immunosorbent assay.

Ejemplares similares